Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal pharmacokinetics of ARA 290 in healthy volunteers
NL-OMON38517Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cibinetide in Neuralgia, sponsored by Leiden University Medical Center. Primary endpoint: Plasma concentration of ARA 290 over time. Started Apr 2013; status: active, not recruiting.
02
Drugs
cibinetide
03
Conditions
Neuralgia
Beyond the preview
Go deeper on NL-OMON38517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38517.